Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
Title of document
Draft resolution 1200, 01 September 2023
Description
This Draft Resolution contains provisions on the establishment of an optimized procedure for the analysis and decision of requests for registration of medical devices, through the use of analyzes carried out by an Equivalent Foreign Regulatory Authority.For the purposes of adopting the optimized analysis procedure, the following AREE and
respective proof of registration or authorization:>I - Australia: Australia Therapeutic Goods Administration (TGA) – Australian Register of Therapeutic
Goods (ARTG);>II - Canada: Health Canada (HC) – Medical Device License;
III - Japan: Japan Ministry of Health, Labor and Welfare (MHLW) – Pre-market approval (Shonin) from
MHLW; It is>IV - United States of America (USA): US Food and Drug Administration (US FDA) – 510K
Clearance or Premarket Approval (PMA).
Notifying member: Brazil
Notification: G/TBT/N/BRA/1500
Objective tag
Protection of human health or safety (TBT)
Documents
Timing:
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions